Document Detail

Gabapentin for relief of spasticity associated with multiple sclerosis.
MedLine Citation:
PMID:  9798839     Owner:  NLM     Status:  MEDLINE    
The use of a recently released anticonvulsant, gabapentin, in the treatment of spasticity in two patients with multiple sclerosis is reported. Gabapentin was chosen because of its GABA-ergic effect and because previously reported studies have shown that it is well tolerated compared with other GABA-mimetic medication. Satisfactory release of spasticity with significant improvement of functional outcome was noted in both cases. Both patients were first treated with gabapentin for one month at 300 mg per day and then, with no reported side-effects, at 400 mg per day. Before treatment, spasticity (graded with modified Ashworth Scale) in one patient was 3 for left lower and 2 for right lower limbs, and Expanded Disability Status Scale (EDSS) was 7; ambulation was limited to a few steps with a standard walker. After two weeks of treatment, spasticity was 2 and 1 for the left and right lower limbs, respectively. At three-month intervals, spasticity was +1 for left and 1 for right lower limbs, and EDSS was 6; the patient could ambulate 75 to 100 m with a standard walker. In the second patient, spasticity before treatment was 2 for both lower and left upper limbs. EDSS was 5.5, and ambulation was confined to 100 m with a cane. Spasticity improved to +1 in lower and 1 in left upper limbs after two weeks and to 1 and normal after three months. At three months, EDSS was 3 and the patient could ambulate for long distances without an assistive device. We suggest that gabapentin can be used effectively to decrease spasticity without significant side effects in patients with multiple sclerosis.
A Dunevsky; A B Perel
Related Documents :
19628359 - Isolated femoral endarterectomy: impact of sfa tasc classification on recurrence of sym...
8792989 - Tcpo2 as an accurate predictor of therapy in limb salvage.
19328029 - Selective and sustained delivery of basic fibroblast growth factor (bfgf) for treatment...
19935589 - Cilostazol may improve outcome in critical limb ischemia.
7850539 - Functional morbidity of hyperthermic isolated regional perfusion of the extremities.
20347549 - Midterm results from a multicenter registry on the treatment of infrainguinal critical ...
2884889 - Comparison of propranolol, sotalol, and betaxolol in the treatment of neuroleptic-induc...
20413439 - Thigh grafts contribute significantly to patients' time on dialysis.
25099819 - Predicting a successful ureteral access sheath insertion: a bi-center prospective study.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  American journal of physical medicine & rehabilitation / Association of Academic Physiatrists     Volume:  77     ISSN:  0894-9115     ISO Abbreviation:  Am J Phys Med Rehabil     Publication Date:    1998 Sep-Oct
Date Detail:
Created Date:  1998-11-16     Completed Date:  1998-11-16     Revised Date:  2013-06-11    
Medline Journal Info:
Nlm Unique ID:  8803677     Medline TA:  Am J Phys Med Rehabil     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  451-4     Citation Subset:  AIM; IM    
Department of Rehabilitation Medicine, Kingsbrook Jewish Medical Center, Brooklyn, New York 11203, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acetates / administration & dosage,  therapeutic use*
Anticonvulsants / administration & dosage,  therapeutic use*
Cyclohexanecarboxylic Acids*
Middle Aged
Multiple Sclerosis / drug therapy*
Muscle Spasticity / drug therapy*
Parasympatholytics / administration & dosage,  therapeutic use*
gamma-Aminobutyric Acid*
Reg. No./Substance:
0/Acetates; 0/Amines; 0/Anticonvulsants; 0/Cyclohexanecarboxylic Acids; 0/Parasympatholytics; 56-12-2/gamma-Aminobutyric Acid; 6CW7F3G59X/gabapentin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Comparative study of the effect of ultrasound and electrostimulation on bone healing in rats.
Next Document:  Heterotopic ossification in moyamoya disease: a case report.